FinTechsDepot FinTechsDepot - Empowering FinTech Futures: Where Knowledge Fuels Innovation.

  • HOME
  • ARTICLES
    • Digital banking
  • RESOURCES
    • Whitepaper
    • Infographics
  • GLOBENEWSWIRE NEWS
  • EVENTS
    • Upcoming conference
    • Past Conference
    • Webinar
  • Contact Us
FinTechsDepot
Whitepaper

Cards and Payments: Delivering the Digital Opportunity

Admin May 29, 2026 0
Whitepaper

Banking, Finance & Investment

Whitepaper

“Generative AI Trends Among U.S. Financial Advisors and…

Whitepaper

Financial Services for Agriculture

Banking

Embedded Finance and Open Banking Redefine Financial Services

Articles

Life After QuickBooks: Why It’s Time to Step Up to Sage Intacct for Business-Class…

Admin May 18, 2026 0
For many small and midsized businesses, Intuit QuickBooks is the preferred choice for financial software in the…
Whitepaper

How Your Personality Is Impacting Your Finances

Admin May 15, 2026
Your personality impacts how you make decisions in almost every area of your life. Your career, relationships,…
Articles

Understanding Credit Card Losses: Causes, Prevention, and Recovery

Admin May 14, 2026
Credit cards are a convenient financial tool used by millions of people worldwide for everyday purchases,…
Whitepaper

Everything You Should Know About Contactless Payments

Admin May 13, 2026
For years, shoppers in Europe and Asia have been paying with contactless methods such as mobile wallets and…
Whitepaper

Embedded banking but not as you know it

Admin May 12, 2026
Every now and then the fintech sector finds itself impacted by a wave of technological innovation, which marks the…
Articles

How Smart Money Management and Digital Trends Are Reshaping Wealth in 2026

Admin May 11, 2026
In today’s fast-moving world, finance is no longer just about saving money in a bank account or investing in…
Whitepaper

INVESTMENT GUIDE Investing for your future

Admin May 8, 2026
Everything we do at Australian Super is designed to help everyday Australians achieve their best retirement. As…
Whitepaper

5 Approaches to Scaling Finance Accuracy with AI

Admin May 6, 2026
Finance teams often waste hours reconciling spreadsheets, documenting controls, and applying business logic…
Whitepaper

Understanding the Financial Interest Clause

Admin May 5, 2026
A Financial Interest Clause (FIC) is one of many options available to companies with multinational exposures. Like…
Banking

How the Fintech Industry is Redefining the Future of Financial Services

Admin May 4, 2026
The banking profession has undergone a remarkable transformation over the past few decades, shifting from…
Featured News

Global Financial Markets Navigate Volatility Amid Rate Uncertainty and Digital…

Admin Apr 30, 2026
Global financial markets today are witnessing a cautious yet dynamic phase as investors, policymakers, and…
Featured News

Fintech Disruption Meets Taxation Reform: Digital Finance Reshapes Global…

Admin Apr 29, 2026
The convergence of fintech innovation and evolving taxation frameworks is emerging as one of the most…
Whitepaper

Climate-Related Financial Risk

Admin Apr 28, 2026
Climate-related financial risk has become a prominent theme that is high on the agenda of U.S. and European…
Infographics

10 Ways AI Chatbots Can Transform the Banking Industry

Admin Apr 27, 2026
A chatbot is a piece of software that can share information and answer questions in a conversational style.…
Featured News

AI-Powered Fintech Revolution Reshapes Global Banking and Payments in 2026

Admin Apr 24, 2026
The global fintech industry in 2026 is undergoing a rapid transformation driven by artificial intelligence,…
Articles

AI in Banking: A Review of the Top 7 Banks in America

Admin Apr 23, 2026
Even the established banks are beginning to show interest in and implement artificial intelligence (AI), despite…
Featured News

Volatility Surges as Global Events Reshape Currency Markets

Admin Apr 22, 2026
The global forex trading landscape in 2026 is witnessing heightened volatility as geopolitical tensions, central…
Articles

Cylinder Crisis in India: Rising LPG Costs Push Households Toward Financial Strain

Admin Apr 21, 2026
India is currently witnessing a growing concern over the rising cost and accessibility of domestic LPG cylinders,…
Articles

The Best Advanced Payment Options You Should Be Aware Of

Admin Apr 16, 2026
Essential Payment Solutions for Your Business Running a business involves many considerations, with payment…
Articles

Will fintech impact daily life in Asia and Africa?

Admin Apr 15, 2026
The contemporary world is ever-evolving and provides society with more resources than in the past. Millions of…
Featured News

Fintech Innovation Accelerates in 2026 as Digital Payments and AI Redefine…

Admin Apr 14, 2026
The fintech industry is witnessing rapid evolution in 2026, driven by the growing adoption of digital payments,…
Featured News

US Dollar vs Indian Rupee in 2026: Currency Pressure Continues to Shape India’s…

Admin Apr 13, 2026
In 2026, the ongoing battle between the US Dollar and the Indian Rupee remains a key focus for economists,…
Upcoming conference

The Future of Finance: Navigating Innovation, Risk, and Global Growth

Admin Apr 10, 2026
The global finance industry is gearing up for a dynamic year ahead, with several high-impact conferences set to…
Whitepaper

DRIVING SALESFORCE FINANCIAL SERVICE CLOUD ADOPTION IN BANKS

Admin Apr 9, 2026
While it may seem like common sense alone would influence end users to adopt the superior FSC tools that you are…
Featured News

Through a new partnership, Glia’s digital interaction solutions are now…

Admin Apr 8, 2026
In order to simplify digital-first member service, Glia, the leader in customer interactions that unifies…
Whitepaper

Life After QuickBooks: Why It’s Time to Step Up to Sage Intacct for Business-Class…

Admin Apr 7, 2026
For many small and mid-sized businesses, Intuit QuickBooks is the preferred choice for financial software in the…
Articles

Fintech Revolution 2026: AI, Stablecoins, and Global Expansion Reshape Financial…

Admin Apr 6, 2026
The global fintech industry in 2026 is witnessing a powerful transformation driven by artificial intelligence,…
Articles

The Role of Finance Management Software in Corporate Organizations

Admin Apr 2, 2026
Finance management software has become indispensable in corporate organizations, revolutionizing the way…
Featured News

Rupee vs Dollar Debate Intensifies: Economic Reality or Political Narrative?

Admin Apr 1, 2026
A fresh wave of debate has erupted across India’s financial and political landscape over the long-standing…
Whitepaper

FinTechnicolor: The New Picture in Finance

Admin Mar 31, 2026
Banking has historically been one of the business sectors most resistant to disruption by technology. Since the…
Articles

Capital Markets: The Significance of Today’s Advance for the Aussie and…

Admin Mar 30, 2026
Global capital markets are experiencing a notable shift as both the Australian dollar (Aussie) and the British…
Whitepaper

The Power of Ecosystems for Banking

Admin Mar 25, 2026
Banking is being changed from within as the Banking-as-a-Serivce (BaaS) model and real-time payments (RTP) take…
1 2 3 … 14 Next

    SUBSCRIBE NOW


    Via Email
    Via Telephone


    I Agree. I would like to share my information with FinTechsDepot & their partners so that I can receive relevant information about products, services, & offers.

    RECENT POST

    • Cards and Payments: Delivering the Digital Opportunity
    • Banking, Finance & Investment
    • “Generative AI Trends Among U.S. Financial Advisors and Consumers”
    • Financial Services for Agriculture
    • Embedded Finance and Open Banking Redefine Financial Services

    ARTICLE

    Precede Biosciences Presents New ASCO 2026 Data Demonstrating Ability of Precede Bio Insight™ to Decode MET-Driven Biology and Resistance in Advanced NSCLC
    2026-05-31T14:00:00Z
    BOSTON, May 31, 2026 (GLOBE NEWSWIRE) -- Precede Biosciences, a company powering next-generation precision medicine through its functional liquid biopsy platform, today announced two new data presentations at the 2026...


    Immatics Presents Data on IMA401 MAGEA4/8 Bispecific at 2026 ASCO Annual Meeting with Simultaneous Publication in Nature Medicine Supporting Development of IMA401/IMA402 Combination in Lung Cancer
    2026-05-31T13:00:00Z
    Houston, Texas and Tuebingen, Germany, May 31, 2026 – Immatics N.V. (NASDAQ: IMTX, “Immatics” or the “Company”), the global leader in precision targeting of PRAME with multiple clinical-stage programs spanning...


    Johnson & Johnson's Phase 3 prostate cancer study shows ERLEADA® (apalutamide) before and after surgery significantly reduces risk of metastasis or death, versus hormone therapy alone, potentially shifting a decades-long treatment paradigm
    2026-05-31T12:39:57Z
    Compared with patients receiving hormone therapy alone, patients were nine times more likely to have little to no cancer remaining in the prostate after surgery, with a 20 percent reduction...


    Revolution Medicines Announces ASCO Plenary Presentation Highlighting Unprecedented Results from Pivotal Phase 3 RASolute 302 Clinical Trial of Daraxonrasib in Previously Treated Metastatic Pancreatic Cancer
    2026-05-31T12:06:00Z
    Results simultaneously published in The New England Journal of Medicine


    Immunocore presents updated Phase 1 data of brenetafusp in patients with heavily pretreated advanced melanoma
    2026-05-31T12:00:00Z
    Immunocore presents updated Phase 1 data of brenetafusp in patients with heavily pretreated advanced melanoma


    Replimune Presents Final First-in-Human Data for RP2 in Advanced Solid Tumors During Oral Presentation at the 2026 American Society of Clinical Oncology Annual Meeting
    2026-05-31T12:00:00Z
    WOBURN, Mass., May 31, 2026 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (NASDAQ: REPL), a clinical-stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today presented final first-in-human data for...


    SlimTide Truth Revealed (2026 Official Website Risk Warning) Avoid Hidden Fees & Fake Complaints
    2026-05-31T10:31:00Z
    SlimTide Prebiotic Probiotic Formula for Gut Health and Metabolic Support: Ingredients, Side Effects, Dosage, and 60-Day Guarantee Breakdown


    NeuExcell Therapeutics Announces Encouraging Data of NXL-004 in Recurrent Malignant Glioma at 2026 ASCO
    2026-05-31T10:00:00Z
    CHICAGO, May 31, 2026 (GLOBE NEWSWIRE) -- NeuExcell Therapeutics today announced that Dr. Yulun Huang will present the first-in-human clinical study of NXL-004 for recurrent malignant glioma as Rapid Oral...


    Pluvicto™ demonstrated consistent efficacy across key patient subgroups in metastatic hormone-sensitive prostate cancer
    2026-05-31T05:15:00Z
    Basel, May 31, 2026 – Novartis today announced results showing consistent radiographic progression-free survival (rPFS) improvement across key subgroups with Pluvicto™ (lutetium Lu 177 vipivotide tetraxetan) plus standard of care...


    Orion Pharma announces first results from Phase 1/2 TEADES trial with TEAD inhibitor ODM-212 in patients with advanced solid tumours
    2026-05-30T18:30:00Z
    ORION CORPORATION PRESS RELEASE 30 MAY 2026 at 21:30 EEST


    Eikon Therapeutics Presents Data on Clinical-Stage Programs at the 2026 Annual Meeting of the American Society of Clinical Oncology
    2026-05-30T18:30:00Z
    MILLBRAE, Calif., May 30, 2026 (GLOBE NEWSWIRE) -- Eikon Therapeutics, Inc. (Nasdaq: EIKN) (Eikon), a late-stage clinical biopharmaceutical company dedicated to developing innovative medicines to address serious unmet medical needs,...


    Global Data for BioNTech and Bristol Myers Squibb’s PD-L1xVEGF-A Bispecific Pumitamig Shows Encouraging Efficacy in Patients with Non-Small Cell Lung Cancer in ROSETTA Lung-02 Trial
    2026-05-30T18:15:00Z
    MAINZ, Germany, and PRINCETON, USA, May 30, 2026 – BioNTech SE (Nasdaq: BNTX, “BioNTech”) and Bristol Myers Squibb Company (NYSE: BMY, “BMS”) today announced interim Phase 2 data from the...


    ITM Announces Phase 3 COMPETE Patient-Reported Quality of Life Data with n.c.a. ¹⁷⁷Lu-edotreotide (ITM-11) vs. Everolimus at ASCO 2026
    2026-05-30T17:00:00Z
    Chicago, Illinois, May 30, 2026 — ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, today announced encouraging Health-Related Quality of Life (HRQoL) data from its Phase 3...


    Mineralys Therapeutics Presents New Data from the Phase 3 Launch-HTN Trial of Lorundrostat in Participants with Hypertension and Chronic Kidney Disease at European Meeting on Hypertension and Cardiovascular Protection (ESH 2026)
    2026-05-30T15:15:00Z
    – Post hoc analysis from pivotal Launch-HTN trial shows statistically significant and clinically meaningful reductions in blood pressure in participants with chronic kidney disease –


    ImPact Biotech Presents Updated Data from Phase 1 Trial of Padeliporfin VTP in LA-PDAC and Phase 3 ENLIGHTED Trial in LG-UTUC at ASCO 2026
    2026-05-30T14:00:00Z
    – Updated data across two dose levels of 200 mW/cm and 400 mW/cm in LA-PDAC trial show 71% (5/7) patients resected following VTP with a consistent and well-tolerated safety profile...


    Momcozy Launches Plus Baby Wipes Built for Every “Messy Milestone”: 99% Purified Water, 8″ × 8″, Independently Certified by Intertek
    2026-05-30T13:00:00Z
    Designed around the “Bring On The Mess” philosophy, the new wipes are larger than most leading brands by sheet dimensions, formulated with 99% purified water and coconut extract, and independently...


    Cogent Biosciences Announces Detailed Clinical Data from PEAK Phase 3 Trial with Bezuclastinib in Combination with Sunitinib in Gastrointestinal Stromal Tumors (GIST) at 2026 American Society of Clinical Oncology (ASCO) Annual Meeting
    2026-05-30T12:00:00Z
    Bezuclastinib combination is first treatment ever to demonstrate statistically significant advantage against active comparator in GIST patients; median PFS of 16.5 months versus 9.2 months (HR=0.50, CI: 0.39-0.65, p<0.0001) for...


    Replimune Presents 3-Year Landmark Overall Survival Analysis from IGNYTE Clinical Trial During Oral Presentation at the 2026 American Society of Clinical Oncology Annual Meeting
    2026-05-30T12:00:00Z
    WOBURN, Mass., May 30, 2026 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (NASDAQ: REPL), a clinical-stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today presented 3-year landmark overall survival...


    Immatics Presents Clinical Activity of IMA203CD8 PRAME Cell Therapy in Hard-to-Treat Gynecologic Cancers at 2026 ASCO Annual Meeting
    2026-05-30T12:00:00Z
    Houston, Texas and Tuebingen, Germany, May 30, 2026 – Immatics N.V. (NASDAQ: IMTX, “Immatics” or the “Company”), the global leader in precision targeting of PRAME with multiple clinical-stage programs spanning...


    How Riccio Pharmacy Makes Online Medicine Delivery Easier For Patients?
    2026-05-30T10:00:01Z
    Pennsylvania, United States, May 30, 2026 (GLOBE NEWSWIRE) -- Healthcare has changed rapidly over the last few years, and many patients now prefer the convenience of online pharmacy services over...


    Mikey Moran Launches GLZD, Combining Skincare and Fragrance Into Men’s Grooming Routine
    2026-05-30T06:09:36Z
    Atlanta, GA, May 30, 2026 (GLOBE NEWSWIRE) -- Beauty entrepreneur Mikey Moran has officially launched GLZD, a new men’s grooming brand introducing “body glaze”—a water-free product category designed to combine skincare,...


    Bioma Probiotics Claims Evaluated: What the 2026 Gut Health Research Reveals About This Seed Probiotics Alternative, Its Ingredients, Weight Loss Support, and Consumer Reviews
    2026-05-30T02:08:28Z
    An independent, research-informed evaluation of the Bioma probiotic formulation — examining its ingredients, dosage disclosure, weight-loss positioning, consumer reviews, and what buyers should verify before purchasing.


    Celularity Receives Nasdaq Notice Regarding Form 10-Q
    2026-05-29T21:15:00Z
    FLORHAM PARK, N.J., May 29, 2026 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (the “Company”), a longevity-focused regenerative and cellular medicine company, today announced that it received a notification letter...


    Kane Biotech Announces Grant of Stock Options
    2026-05-29T21:05:00Z
    Not for distribution to U.S. news wire services or dissemination in the United States


    Quest PharmaTech Provides Corporate Update including Voluntary Adoption of CSA Blanket Order 51-93 to File Financial Statements and MD&A on Semi-Annual Basis
    2026-05-29T21:00:00Z
    EDMONTON, Alberta, May 29, 2026 (GLOBE NEWSWIRE) -- Quest PharmaTech Inc. (TSX-V: QPT) (“Quest” or the “Company”), a Canadian based pharmaceutical company developing products to improve the quality of life...


    Transactions with Shares and Linked Securities in Genmab A/S Made by Managerial Employees and Their Closely Associated Persons
    2026-05-29T20:35:07Z
    Company Announcement


    Zevra Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
    2026-05-29T20:30:00Z
    BOSTON, May 29, 2026 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage company focused on bringing life-changing therapeutics to people living with rare diseases,...


    Crescent Biopharma Announces Grants of Inducement Awards
    2026-05-29T20:15:00Z
    WALTHAM, Mass., May 29, 2026 (GLOBE NEWSWIRE) -- Crescent Biopharma, Inc. (“Crescent” or the “Company”) (Nasdaq: CBIO), a clinical-stage biotechnology company dedicated to rapidly advancing the next wave of therapies...


    Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities
    2026-05-29T20:05:00Z
    ZUG, Switzerland, May 29, 2026 (GLOBE NEWSWIRE) -- The attached notification relates to the vesting and settlement of RSUs previously granted to a director of the Company.


    Jade Biosciences to Host Conference Call and Webcast on June 1, 2026, at 8:00 a.m. ET to Discuss Interim Phase 1 Healthy Volunteer Results for JADE101, a Novel, Potentially Best-in-Class Anti-APRIL Monoclonal Antibody in Development for IgA Nephropathy
    2026-05-29T20:05:00Z
    SAN FRANCISCO and VANCOUVER, British Columbia, May 29, 2026 (GLOBE NEWSWIRE) -- Jade Biosciences, Inc. (the “Company” or “Jade”) (Nasdaq: JBIO), a clinical-stage biotechnology company focused on developing best-in-class therapies...

    Copyright © 2026 | FinTechsDepot | All Rights Reserved |
    Privacy Policy | Unsubscribe
    Sign in

    Welcome, Login to your account.

    Forget password?
    Sign in

    Recover your password.

    A password will be e-mailed to you.